HHC banned, make way for H4CBD
Following the ban on the sale and consumption of hexahydrocannabinol (HHC) in France, retailers are now turning to molecules with similar effects. Among them, H4CBD, a derivative of CBD (cannabidiol), is generating interest and should be available for sale soon.Origin and availability of H4CBD The new derivative comes primarily from Italy or France and is expected to hit the market during the summer of 2023. CBD retailers are counting on this new molecule to compensate for the absence of HHC on their shelves. Alleged effects of H4CBDLike its predecessor, H4CBD is supposed to replicate some of the relaxing and calming effects of cannabis without causing addiction or psychotropic effects. It is still too early to know the precise effects of this new molecule, but initial studies seem to show similarities with CBD: Anti-inflammatory properties Relaxing effects
Potential anxiety reduction
Relief from certain types of pain
Effect of H4CBD on the body
A potential risk of abuse and addiction?
- While HHC has been banned due to risks of abuse and addiction equivalent to those of cannabis, it remains to be seen whether H4CBD will present the same problems. Studies on this new molecule are still underway, and we will have to wait for their results to learn more about the potential dangers of H4CBD consumption.
- Legality and regulation of H4CBD
- For the moment, H4CBD is not yet subject to the ban that affects HHC and its derivatives. However, it is highly likely that its regulation will be closely monitored by the relevant authorities, such as the French National Agency for Medicines and Health Products Safety (ANSM). The CBD market is constantly evolving
- Faced with the various laws and restrictions affecting the CBD and CBD derivatives market, retailers and producers are constantly seeking new alternatives to meet growing consumer demand. H4CBD is one such innovation, although it remains to be seen whether this molecule will be spared from future bans or strict regulations.
H4CBD appears as a promising alternative to the now-prohibited HHC, but many questions remain regarding its effects and legality. Ongoing studies should lead to a better understanding of this new molecule and inform consumers about its potential benefits and risks.
In the meantime, retailers hope to capitalize on this new opportunity to continue offering CBD products to customers seeking relaxation and well-being, while remaining compliant with current legislation.
